|
1
|
Forner A, Reig M and Bruix J:
Hepatocellular carcinoma. Lancet. 391:1301–1314. 2018. View Article : Google Scholar
|
|
2
|
El-Serag HB: Epidemiology of viral
hepatitis and hepatocellular carcinoma. Gastroenterology.
142:1264–1273.e1. 2012.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Tajiri H, Tanaka H, Brooks S and Takano T:
Reduction of hepatocellular carcinoma in childhood after
introduction of selective vaccination against hepatitis B virus for
infants born to HBV carrier mothers. Cancer Causes Control.
22:523–527. 2011.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Tanaka Y, Hanada K, Mizokami M, Yeo AE,
Shih JW, Gojobori T and Alter HJ: A comparison of the molecular
clock of hepatitis C virus in the United States and Japan predicts
that hepatocellular carcinoma incidence in the United States will
increase over the next two decades. Proc Natl Acad Sci USA.
99:15584–15589. 2002.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Altekruse SF, McGlynn KA and Reichman ME:
Hepatocellular carcinoma incidence, mortality, and survival trends
in the United States from 1975 to 2005. J Clin Oncol. 27:1485–1491.
2009.PubMed/NCBI View Article : Google Scholar
|
|
6
|
El-Serag HB: Hepatocellular carcinoma:
Recent trends in the United States. Gastroenterology. 127 (5 Suppl
1):S27–S34. 2004.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Li T, Zhu Y, Qin CY, Yang Z, Fang A, Xu S
and Ren W: Expression and prognostic significance of vascular
endothelial growth factor receptor 1 in hepatocellular carcinoma. J
Clin Pathol. 65:808–814. 2012.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Vilchez V, Turcios L, Marti F and Gedaly
R: Targeting Wnt/β-catenin pathway in hepatocellular carcinoma
treatment. World J Gastroenterol. 22:823–832. 2016.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Intharit N: Cytotoxic activity of
benjaummarit remedy against cancer cells and its biological
activities. Patumthani. Thammasat University Press, 2012.
|
|
10
|
Yaprasert R, Sripanidkulchai B,
Teerachaisakul M, Bancheon K and Banjerdpongchai R: A Thai herbal
formula benja amarit efficiently suppresses lung and liver cancer
cells proliferation through inducing ROS-mediated apoptosis. In:
International conference on liver and lung cancer: Current and
future research, Bangkok, Thailand, January 8-10: 93, 2019.
|
|
11
|
Yan F, Wang M, Li J, Cheng H, Su J, Wang
X, Wu H, Xia L, Li X, Chang HC and Li Q: Gambogenic acid induced
mitochondrial-dependent apoptosis and referred to phospho-Erk1/2
and phospho-p38 MAPK in human hepatoma HepG2 cells. Environ Toxicol
Pharmacol. 33:181–190. 2012.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Xie H, Qin YX, Zhou YL, Tong LJ, Lin LP,
Geng MY, Duan WH and Ding J: GA3, a new gambogic acid derivative,
exhibits potent antitumor activities in vitro via
apoptosis-involved mechanisms. Acta Pharmacol Sin. 30:346–354.
2009.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Zou Z, Xie L, Wei J, Yu L, Qian X, Chen J,
Wang T and Liu B: Synergistic anti-proliferative effects of
gambogic acid with docetaxel in gastrointestinal cancer cell lines.
BMC Complement Altern Med. 12(58)2012.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Guo XK, Sun HP, Shen S, Sun Y, Xie FL, Tao
L, Guo QL, Jiang C and You QD: Synthesis and evaluation of gambogic
acid derivatives as antitumor agents. Part III. Chem Biodivers.
10:73–85. 2013.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Abdel-Raheem IT and Abdel-Ghany AA:
Hesperidin alleviates doxorubicin-induced cardiotoxicity in rats. J
Egypt Natl Canc Inst. 21:175–184. 2009.PubMed/NCBI
|
|
16
|
Lu N, Yang Y, You QD, Ling Y, Gao Y, Gu
HY, Zhao L, Wang XT and Guo QL: Gambogic acid inhibits angiogenesis
through suppressing vascular endothelial growth factor-induced
tyrosine phosphorylation of KDR/Flk-1. Cancer Lett. 258:80–89.
2007.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Lu N, Hui H, Yang H, Zhao K, Chen Y, You
QD and Guo QL: Gambogic acid inhibits angiogenesis through
inhibiting PHD2-VHL-HIF-1α pathway. Eur J Pharm Sci. 49:220–226.
2013.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Qiang L, Yang Y, You QD, Ma YJ, Yang L,
Nie FF, Gu HY, Zhao L, Lua N, Qi Q, et al: Inhibition of
glioblastoma growth and angiogenesis by gambogic acid: An in vitro
and in vivo study. Biochem Pharmacol. 75:1083–1092. 2008.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Yi T, Yi Z, Cho SG, Luo J, Pandey MK,
Aggarwal BB and Liu M: Gambogic acid inhibits angiogenesis and
prostate tumor growth by suppressing vascular endothelial growth
factor receptor 2 signaling. Cancer Res. 68:1843–1850.
2008.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Cascão R, Vidal B, Raquel H, Neves-Costa
A, Figueiredo N, Gupta V, Fonseca JE and Moita LF: Potent
anti-inflammatory and antiproliferative effects of gambogic acid in
a rat model of antigen-induced arthritis. Mediators Inflamm.
2014(195327)2014.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Panthong A, Norkaew P, Kanjanapothi D,
Taesotikul T, Anantachoke N and Reutrakul V: Anti-inflammatory,
analgesic and antipyretic activities of the extract of gamboge from
Garcinia hanburyi Hook f. J Ethnopharmacol. 111:335–340.
2007.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Wen J, Pei H, Wang X, Xie C, Li S, Huang
L, Qiu N, Wang W, Cheng X and Chen L: Gambogic acid exhibits
anti-psoriatic efficacy through inhibition of angiogenesis and
inflammation. J Dermatol Sci. 74:242–250. 2014.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Qi Q, Lu N, Li C, Zhao J, Liu W, You Q and
Guo Q: Involvement of RECK in gambogic acid induced anti-invasive
effect in A549 human lung carcinoma cells. Mol Carcinog. 54 (Suppl
1):E13–E25. 2015.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Xin ZF, Shen CC, Tao LJ, Yan SG and Wu HB:
Gambogic acid inhibits invasion of osteosarcoma via upregulation of
TIMP-1. Int J Mol Med. 31:105–112. 2013.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Chen J, Gu HY, Lu N, Yang Y, Liu W, Qi Q,
Rong JJ, Wang XT, You QD and Guo QL: Microtubule depolymerization
and phosphorylation of c-Jun N-terminal kinase-1 and p38 were
involved in gambogic acid induced cell cycle arrest and apoptosis
in human breast carcinoma MCF-7 cells. Life Sci. 83:103–109.
2008.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Li R, Chen Y, Zeng LL, Shu WX, Zhao F, Wen
L and Liu Y: Gambogic acid induces G0/G1 arrest and apoptosis
involving inhibition of SRC-3 and inactivation of Akt pathway in
K562 leukemia cells. Toxicology. 262:98–105. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Li C, Lu N, Qi Q, Li F, Ling Y, Chen Y,
Qin Y, Li Z, Zhang H, You Q and Guo Q: Gambogic acid inhibits tumor
cell adhesion by suppressing integrin β1 and membrane lipid
rafts-associated integrin signaling pathway. Biochem Pharmacol.
82:1873–1883. 2011.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Yossathera K, Worakunphanich W,
Teerachaisakul M and Stienrut P: Traditional Thai medicine formula
‘Benja Amarit’ in liver cancer patients: A safety and quality of
life. J Thai Tradit Alterna Med. 15:301–311. 2017.
|
|
29
|
El-Ashmawy NE, El-Bahrawy HA, Shamloula MM
and El-Feky OA: Biochemical/metabolic changes associated with
hepatocellular carcinoma development in mice. Tumour Biol.
35:5459–5466. 2014.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Liu L, Cao Y, Chen C, Zhang X, McNabola A,
Wilkie D, Wilhelm S, Lynch M and Carter C: Sorafenib blocks the
RAF/MEK/ERK pathway, inhibits tumor angiogenesis, and induces tumor
cell apoptosis in hepatocellular carcinoma model PLC/PRF/5. Cancer
Res. 66:11851–11858. 2006.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Kuczynski EA, Lee CR, Man S, Chen E and
Kerbel RS: Effects of sorafenib dose on acquired reversible
resistance and toxicity in hepatocellular carcinoma. Cancer Res.
75:2510–2519. 2015.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Kiroplastis K, Fouzas I, Katsiki E,
Patsiaoura K, Daoudaki M, Komninou A, Xolongitas E, Katsika E,
Kaidoglou K and Papanikolaou V: The effect of sorafenib on liver
regeneration and angiogenesis after partial hepatectomy in rats.
Hippokratia. 19:249–255. 2015.PubMed/NCBI
|
|
33
|
Kissel M, Berndt S, Fiebig L, Kling S, Ji
Q, Gu Q, Lang T, Hafner FT, Teufel M and Zopf D: Antitumor effects
of regorafenib and sorafenib in preclinical models of
hepatocellular carcinoma. Oncotarget. 8:107096–107108.
2017.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Lee Y, Lee SS, Cheong H, Lee CK, Kim N,
Son WC and Hong SM: Intravoxel incoherent motion MRI for monitoring
the therapeutic response of hepatocellular carcinoma to sorafenib
treatment in mouse xenograft tumor models. Acta Radiol.
58:1045–1053. 2017.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Schlageter M, Terracciano LM, D'Angelo S
and Sorrentino P: Histopathology of hepatocellular carcinoma. World
J Gastroenterol. 20:15955–15964. 2014.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2-ΔΔCT method. Methods. 25:402–408. 2001.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Pan Q, Pan H, Lou H, Xu Y and Tian L:
Inhibition of the angiogenesis and growth of Aloin in human
colorectal cancer in vitro and in vivo. Cancer Cell Int.
13(69)2013.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Suboj P, Babykutty S, Valiyaparambil Gopi
DR, Nair RS, Srinivas P and Gopala S: Aloe emodin inhibits colon
cancer cell migration/angiogenesis by downregulating MMP-2/9, RhoB
and VEGF via reduced DNA binding activity of NF-κB. Eur J Pharm
Sci. 45:581–591. 2012.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Kim KH, Lee HJ, Jeong SJ, Lee HJ, Lee EO,
Kim HS, Zhang Y, Ryu SY, Lee MH, Lü J and Kim S: Galbanic acid
isolated from Ferula assafoetida exerts in vivo anti-tumor activity
in association with anti-angiogenesis and anti-proliferation. Pharm
Res. 28:597–609. 2011.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Kim EC, Min JK, Kim TY, Lee SJ, Yang HO,
Han S, Kim YM and Kwon YG: [6]-Gingerol, a pungent ingredient of
ginger, inhibits angiogenesis in vitro and in vivo. Biochem Biophys
Res Commun. 335:300–308. 2005.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Rhode J, Fogoros S, Zick S, Wahl H,
Griffith KA, Huang J and Liu JR: Ginger inhibits cell growth and
modulates angiogenic factors in ovarian cancer cells. BMC
Complement Altern Med. 7(44)2007.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Weng CJ, Chou CP, Ho CT and Yen GC:
Molecular mechanism inhibiting human hepatocarcinoma cell invasion
by 6-shogaol and 6-gingerol. Mol Nutr Food Res. 56:1304–1314.
2012.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Raj L, Ide T, Gurkar AU, Foley M, Schenone
M, Li X, Tolliday NJ, Golub TR, Carr SA, Shamji AF, et al:
Selective killing of cancer cells by a small molecule targeting the
stress response to ROS. Nature. 475:231–234. 2011.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Doucette CD, Hilchie AL, Liwski R and
Hoskin DW: Piperine, a dietary phytochemical, inhibits
angiogenesis. J Nutr Biochem. 24:231–239. 2013.PubMed/NCBI View Article : Google Scholar
|
|
45
|
Guo QL, You QD, Wu ZQ, Yuan ST and Zhao L:
General gambogic acids inhibited growth of human hepatoma SMMC-7721
cells in vitro and in nude mice. Acta Pharmacol Sin. 25:769–774.
2004.PubMed/NCBI
|
|
46
|
Chang X, Zhao J, Tian F, Jiang Y, Lu J, Ma
J, Zhang X, Jin J, Huang Y, Dong Z, et al: Aloe-emodin suppresses
esophageal cancer cell TE1 proliferation by inhibiting AKT and ERK
phosphorylation. Oncol Lett. 12:2232–2238. 2016.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Chen HC, Hsieh WT, Chang WC and Chung JG:
Aloe-emodin induced in vitro G2/M arrest of cell cycle in human
promyelocytic leukemia HL-60 cells. Food Chem Toxicol.
42:1251–1257. 2004.PubMed/NCBI View Article : Google Scholar
|
|
48
|
Choi JS, Ryu J, Bae WY, Park A, Nam S, Kim
JE and Jeong JW: Zingerone suppresses tumor development through
decreasing cyclin D1 expression and inducing mitotic arrest. Int J
Mol Sci. 19(pii: E2832)2018.PubMed/NCBI View Article : Google Scholar
|
|
49
|
Lee SH, Cekanova M and Baek SJ: Multiple
mechanisms are involved in 6-gingerol-induced cell growth arrest
and apoptosis in human colorectal cancer cells. Mol Carcinog.
47:197–208. 2008.PubMed/NCBI View Article : Google Scholar
|
|
50
|
Jyothi D, Vanathi P, Mangala Gowri P, Rama
Subba Rao V, Madhusudana Rao J and Sreedhar AS: Diferuloylmethane
augments the cytotoxic effects of piplartine isolated from Piper
chaba. Toxicol In Vitro. 23:1085–1091. 2009.PubMed/NCBI View Article : Google Scholar
|
|
51
|
Fofaria NM, Kim SH and Srivastava SK:
Piperine causes G1 phase cell cycle arrest and apoptosis in
melanoma cells through checkpoint kinase-1 activation. PLoS One.
9(e94298)2014.PubMed/NCBI View Article : Google Scholar
|
|
52
|
Kakarala M, Brenner DE, Korkaya H, Cheng
C, Tazi K, Ginestier C, Liu S, Dontu G and Wicha MS: Targeting
breast stem cells with the cancer preventive compounds curcumin and
piperine. Breast Cancer Res Treat. 122:777–785. 2010.PubMed/NCBI View Article : Google Scholar
|
|
53
|
Lai LH, Fu QH, Liu Y, Jiang K, Guo QM,
Chen QY, Yan B, Wan QQ and Shen JG: Piperine suppresses tumor
growth and metastasis in vitro and in vivo in a 4T1 murine breast
cancer model. Acta Pharmacol Sin. 33:523–530. 2012.PubMed/NCBI View Article : Google Scholar
|
|
54
|
Ouyang DY, Zeng LH, Pan H, Xu LH, Wang Y,
Liu KP and He XH: Piperine inhibits the proliferation of human
prostate cancer cells via induction of cell cycle arrest and
autophagy. Food Chem Toxicol. 60:424–430. 2013.PubMed/NCBI View Article : Google Scholar
|
|
55
|
Yaffe PB, Power Coombs MR, Doucette CD,
Walsh M and Hoskin DW: Piperine, an alkaloid from black pepper,
inhibits growth of human colon cancer cells via G1 arrest and
apoptosis triggered by endoplasmic reticulum stress. Mol Carcinog.
54:1070–1085. 2015.PubMed/NCBI View Article : Google Scholar
|
|
56
|
Nie F, Zhang X, Qi Q, Yang L, Yang Y, Liu
W, Lu N, Wu Z, You Q and Guo Q: Reactive oxygen species
accumulation contributes to gambogic acid-induced apoptosis in
human hepatoma SMMC-7721 cells. Toxicology. 260:60–67.
2009.PubMed/NCBI View Article : Google Scholar
|
|
57
|
Arcella A, Oliva MA, Staffier S, Sanchez
M, Madonna M, Riozzi B, Esposito V, Giangaspero F and Frati L:
Effects of aloe emodin on U87MG glioblastoma cell growth: In vitro
and in vivo study. Environ Toxicol. 33:1160–1167. 2018.PubMed/NCBI View Article : Google Scholar
|
|
58
|
Cherian AM, Snima KS, Kamath CR, Nair SV
and Lakshmanan VK: Effect of Baliospermum montanum nanomedicine
apoptosis induction and anti-migration of prostate cancer cells.
Biomed Pharmacother. 71:201–209. 2015.PubMed/NCBI View Article : Google Scholar
|
|
59
|
Oh BS, Shin EA, Jung JH, Jung DB, Kim B,
Shim BS, Yazdi MC, Iranshahi M and Kim SH: Apoptotic effect of
galbanic acid via activation of caspases and inhibition of Mcl-1 in
H460 non-small lung carcinoma cells. Phytother Res. 29:844–849.
2015.PubMed/NCBI View Article : Google Scholar
|
|
60
|
Ren J, Xu Y, Huang Q, Yang J, Yang M, Hu
K, Hu K and Wei K: Chabamide induces cell cycle arrest and
apoptosis by the Akt/MAPK pathway and inhibition of P-glycoprotein
in K562/ADR cells. Anticancer Drugs. 26:498–507. 2015.PubMed/NCBI View Article : Google Scholar
|
|
61
|
de Souza Grinevicius VM, Kviecinski MR,
Santos Mota NS, Ourique F, Porfirio Will Castro LS, Andreguetti RR,
Gomes Correia JF, Filho DW, Pich CT and Pedrosa RC: Piper nigrum
ethanolic extract rich in piperamides causes ROS overproduction,
oxidative damage in DNA leading to cell cycle arrest and apoptosis
in cancer cells. J Ethnopharmacol. 189:139–147. 2016.PubMed/NCBI View Article : Google Scholar
|
|
62
|
Das A, Miller R, Lee P, Holden CA,
Lindhorst SM, Jaboin J, Vandergrift WA III, Banik NL, Giglio P,
Varma AK, et al: A novel component from citrus, ginger, and
mushroom family exhibits antitumor activity on human meningioma
cells through suppressing the Wnt/β-catenin signaling pathway.
Tumour Biol. 36:7027–7034. 2015.PubMed/NCBI View Article : Google Scholar
|
|
63
|
Kirkland DJ, Aardema M, Banduhn N,
Carmichael P, Fautz R, Meunier JR and Pfuhler S: In vitro
approaches to develop weight of evidence (WoE) and mode of action
(MoA) discussions with positive in vitro genotoxicity results.
Mutagenesis. 22:161–175. 2007.PubMed/NCBI View Article : Google Scholar
|
|
64
|
Walmsley RM and Billinton N: How accurate
is in vitro prediction of carcinogenicity? Br J Pharmacol.
162:1250–1258. 2011.PubMed/NCBI View Article : Google Scholar
|
|
65
|
Nakano M, Tanaka M, Kuromatsu R, Nagamatsu
H, Tajiri N, Satani M, Niizeki T, Aino H, Okamura S, Iwamoto H, et
al: Sorafenib for the treatment of advanced hepatocellular
carcinoma with extrahepatic metastasis: A prospective multicenter
cohort study. Cancer Med. 4:1836–1843. 2015.PubMed/NCBI View Article : Google Scholar
|
|
66
|
Kuroda D, Hayashi H, Nitta H, Imai K, Abe
S, Hashimoto D, Chikamoto A, Ishiko T, Beppu T and Baba H:
Successful treatment for sorafenib-induced liver dysfunction: A
report of case with liver biopsy. Surg Case Rep.
2(4)2016.PubMed/NCBI View Article : Google Scholar
|
